What drugs are included in IRA Medicare price negotiation?

CMS selected the first 10 drugs for negotiation in August 2023, including Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and insulin products. Selection criteria include Medicare Part D spend ranking, time since FDA approval (9+ years for small molecule, 13+ for biologics), and absence of generic/biosimilar competition.